课题基金 / 基金详情

Reduced EtO emissions to safeguard biomedical supply chains

Reduced EtO emissions to safeguard biomedical supply chains
减少环氧乙烷排放以保护生物医学供应链
批准号:
10827793
负责人:
Melissa A Petruska
金额:
$59.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-20 至 2025-08-31

项目摘要

项目成果

Melissa A Petruska的其他基金

相似基金

相关文献

中文摘要
翻译
总结/摘要 该项目的总体目标是保护国家的关键医疗供应链, 使用环氧乙烷(EtO)灭菌的器械。尽管寻找替代品 方法中,大部分一次性使用器械采用EtO灭菌。这些设备,包括 导管、心脏瓣膜和气管切开插管,对于常规和挽救生命的手术至关重要 和治疗。随着环氧乙烷排放法规变得更加严格,以保护工人和 社区免受有害接触,关键供应链存在重大风险, 设备将被破坏,进而威胁到国家的健康和福祉。具体 该项目的目标包括开发一种新型的光催化系统,以减轻环氧乙烷 在危险的水平,但难以解决现有的吸附和热催化 接近。具体而言,该技术解决了浓度在5 ppm和10 ppm范围内的问题。 在灭菌设施、运输和仓库中。这些“逃逸排放”是一种 这是总体排放量的重要贡献者,并直接影响工人和社区安全。 目标包括确定低浓度EtO(<5 ppm) 在99%的破坏和去除效率(DRE)的氧化,通过确定最佳 实现高DRE的光催化剂和参数空间。具体目标是:目标1) 优化100 CFM光反应器流体流量、光功率和99% EtO的催化剂参数 挥发性EtO浓度下的DRE,目标2)开发基于光反应器的100 CFM系统 目标1可以解决现实环境中的EtO排放,目标3)评价 Aim 2 100 CFM系统在灭菌机构中的性能,以及Aim 4)分析Aim 2系统运行寿命因素。各种计算流体动力学和非顺序 光学模型将被实验工作所利用。标准和尖端检测 将使用能够将EtO测量到低ppb和ppt范围内的方法, 实验计划
英文摘要
Summary/Abstract The overarching goal of this project is to protect the nation’s supply chain of critical medical devices that are sterilized using ethylene oxide (EtO). Despite the search for alternative approaches, a large fraction of single-use devices is sterilized with EtO. These devices, including catheters, heart valves, and tracheostomy tubes, are critical to routine and life-saving procedures and therapies. As regulations for EtO emissions become more stringent to protect workers and communities from harmful exposure, there is a significant risk that supply chains for critical devices will be disrupted, in turn threatening the health and well-being of the nation. The specific objectives of this project include the development of a novel photocatalytic system to mitigate EtO at levels that are hazardous but difficult to address with existing adsorptive and thermal catalytic approaches. Specifically, the technology addresses concentrations in the range of 5 ppm and below in sterilization facilities, transportation, and warehouses. These “fugitive emissions” are a significant contributor to overall emissions and directly impact workers and community safety. Objectives include determining operating conditions at which low concentrations of EtO (<5 ppm) are oxidized at 99% destruction and removal efficiency (DRE) by identifying the optimum photocatalyst and parameter space for achieving high DRE. The specific aims are: Aim 1) optimize a 100 CFM photoreactor fluid flow, optical power, and catalyst parameters for 99% EtO DRE at fugitive EtO concentrations, Aim 2) develop a 100 CFM system based on the photoreactor from Aim 1 that can address EtO emissions in a real-world environment, Aim 3) evaluate performance of the Aim 2 100 CFM system in a sterilization facility, and Aim 4) analyze the Aim 2 system operational lifetime factors. Various computational fluid dynamics and non-sequential optical models will be leveraged by the experimental efforts. Standard and cutting-edge detection approaches that are capable of measuring EtO into the low ppb and ppt ranges will be used in the experimental program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reduced EtO emissions to safeguard biomedical supply chains
  • 批准号:
    10547016
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2022
  • 负责人:
    Melissa A Petruska
  • 依托单位:
国内基金
海外基金
组蛋白甲基化酶SETD2和RNA甲基化酶METTL3串扰调控选择性剪接体AML1-ETO9a的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    李永辉
  • 依托单位:
BAHD1在AML1-ETO阳性儿童急性髓系白血病中的表达、促进白血病发生和复发分子机制研究
  • 批准号:
    82370156
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    范会涛
  • 依托单位:
AML1-ETO/SETD8新型复合体增强染色质可及性维持t(8;21)AML白血病干细胞干性的新机制
  • 批准号:
    82304555
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20万元
  • 批准年份:
    2023
  • 负责人:
    苏永伟
  • 依托单位:
双靶向AML1-ETO融合癌蛋白与c-Kit突变体治疗t(8;21)急性髓系白血病的分子机制研究
  • 批准号:
    82370151
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    俞文娟
  • 依托单位: